- Specialty
-
Oncologist, breast and gynecology expert
- Title
-
Assistant department coordinator
- Hospital
-
Centre Léon Bérard (Lyon)
- Latest articles
-
-
ELAINE 3: phase 3 study of lasofoxifene plus abemaciclib to treat ER+/HER2-, ESR1-mutated, metastatic breast cancer.
(May 1, 2025)
-
CAMBRIA-1 & CAMBRIA-2 phase III trials: camizestrant versus standard endocrine therapy in ER+/HER2- early breast cancer.
(Mar 1, 2025)
-
Expert consensus on the prevention of brain metastases in patients with HER2-positive breast cancer.
(Jan 1, 2025)
-
Assessing the real-world effectiveness of 8 major metastatic breast cancer drugs using target trial emulation.
(Dec 1, 2024)
-
Alpelisib plus fulvestrant in PIK3CA-mutated, hormone receptor-positive advanced breast cancer after a CDK4/6 inhibitor (BYLieve): one cohort of a phase 2, multicentre, open-label, non-comparative study.
(Dec 1, 2024)
